Reuters logo
Lilly profit beats forecast
April 24, 2013 / 10:41 AM / 4 years ago

Lilly profit beats forecast

April 24 (Reuters) - Eli Lilly and Co on Wednesday reported higher-than-expected first-quarter earnings, helped by sales of its treatments for diabetes, depression and lung cancer.

The company said it had net income of $1.55 billion, or $1.42 per share. That compared with $1.01 billion, or 91 cents per share, in the year-earlier period.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below